Efficacy of MVA-NP+M1 in the Influenza H3N2 Human Challenge Model
Clinical trial NCT03883113 · COMPLETED
Trial details
- NCT number
- NCT03883113
- Sponsor
- Barinthus Biotherapeutics
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-06-03
- Primary completion
- 2019-12-16
- Enrollment
- 145
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.